PubRank

Thomas R Miller

Author PubWeight™ 41.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hospital episodes and physician visits: the concordance between self-reports and medicare claims. Med Care 2007 1.96
2 Dual use of Medicare and the Veterans Health Administration: are there adverse health outcomes? BMC Health Serv Res 2006 1.22
3 The use of chiropractors by older adults in the United States. Chiropr Osteopat 2007 1.19
4 An interpersonal continuity of care measure for Medicare Part B claims analyses. J Gerontol B Psychol Sci Soc Sci 2007 1.19
5 Effect of subclinical status in functional limitation and disability on adverse health outcomes 3 years later. J Gerontol A Biol Sci Med Sci 2007 1.17
6 Self-rated health: changes, trajectories, and their antecedents among African Americans. J Aging Health 2008 1.08
7 Emergency department utilization patterns among older adults. J Gerontol A Biol Sci Med Sci 2008 1.07
8 Implementation of hospital computerized physician order entry systems in a rural state: feasibility and financial impact. J Am Med Inform Assoc 2004 1.04
9 H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav 2009 1.01
10 Medical homes: "where you stand on definitions depends on where you sit". Med Care Res Rev 2010 0.99
11 Four-year lower extremity disability trajectories among African American men and women. J Gerontol A Biol Sci Med Sci 2007 0.98
12 The economics of specialty hospitals. Med Care Res Rev 2008 0.97
13 Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects. J Pharmacol Exp Ther 2003 0.93
14 The alkaloid conessine and analogues as potent histamine H3 receptor antagonists. J Med Chem 2008 0.92
15 Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties. J Pharmacol Exp Ther 2004 0.91
16 Exploring the association of dual use of the VHA and Medicare with mortality: separating the contributions of inpatient and outpatient services. BMC Health Serv Res 2007 0.91
17 Patient-centered medical homes: will health care reform provide new options for rural communities and providers? Fam Community Health 2011 0.89
18 Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 2012 0.88
19 Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem 2008 0.87
20 Medicaid Personal Care Services and caregivers' reports of children's health: the dynamics of a relationship. Health Serv Res 2011 0.85
21 cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. J Med Chem 2008 0.85
22 Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands. J Med Chem 2008 0.84
23 Severity of children's intellectual disabilities and Medicaid personal care services. Rehabil Psychol 2011 0.83
24 In the United States, "Opt-Out" States Show No Increase in Access to Anesthesia Services for Medicare Beneficiaries Compared with Non-"Opt-Out" States. A A Case Rep 2016 0.83
25 Summarizing activity limitations in children with chronic illnesses living in the community: a measurement study of scales using supplemented interRAI items. BMC Health Serv Res 2012 0.83
26 G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations. J Pharmacol Exp Ther 2005 0.83
27 The perioperative surgical home (PSH): a comprehensive review of US and non-US studies shows predominantly positive quality and cost outcomes. Milbank Q 2014 0.82
28 The Effect of "Opt-Out" Regulation on Access to Surgical Care for Urgent Cases in the United States: Evidence from the National Inpatient Sample. Anesth Analg 2016 0.82
29 Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand. Br J Pharmacol 2006 0.82
30 Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity. Biochem Pharmacol 2007 0.82
31 An 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activity. J Pharmacol Exp Ther 2007 0.81
32 Effects of specialty hospitals on the financial performance of general hospitals, 1997-2004. Inquiry 2007 0.81
33 Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 1. Bioorg Med Chem Lett 2002 0.79
34 Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist. Biochem Pharmacol 2004 0.79
35 Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists. J Med Chem 2007 0.79
36 Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ring. Bioorg Med Chem Lett 2010 0.79
37 Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist. J Med Chem 2004 0.78
38 In vitro SAR of pyrrolidine-containing histamine H3 receptor antagonists: trends across multiple chemical series. Bioorg Med Chem Lett 2007 0.78
39 Synthesis and SAR of 5-amino- and 5-(aminomethyl)benzofuran histamine H3 receptor antagonists with improved potency. J Med Chem 2005 0.78
40 In vitro studies on a class of quinoline containing histamine H3 antagonists. Bioorg Med Chem Lett 2010 0.78
41 4-[6-(2-Aminoethyl)naphthalen-2-yl]benzonitriles are potent histamine H3 receptor antagonists with high CNS penetration. Bioorg Med Chem Lett 2006 0.77
42 Cloning and characterization of the monkey histamine H3 receptor isoforms. Eur J Pharmacol 2008 0.76
43 Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitor. Br J Pharmacol 2003 0.76
44 Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121. Life Sci 2006 0.76
45 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist. Neuropharmacology 2005 0.75
46 The relationship between formal and informal care among adult Medicaid Personal Care Services recipients. Health Serv Res 2012 0.75
47 Differential activation of dual signaling responses by human H1 and H2 histamine receptors. J Recept Signal Transduct Res 2003 0.75
48 "Opt Out" and Access to Anesthesia Care for Elective and Urgent Surgeries among U.S. Medicare Beneficiaries. Anesthesiology 2017 0.75
49 International comparison of preoperative testing and assessment protocols and best practices to reduce surgical care costs: a systematic literature review. Adv Health Care Manag 2015 0.75
50 Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships. J Med Chem 2009 0.75
51 Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists. Bioorg Med Chem Lett 2004 0.75
52 The relationship between advertising, price, and nursing home quality. Health Care Manage Rev 2009 0.75
53 How to evaluate financial risks. Trustee 2011 0.75
54 No significant association between anesthesia group concentration and private insurer payments in the United States. Anesthesiology 2015 0.75
55 Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs. Bioorg Med Chem Lett 2002 0.75
56 In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists. Basic Clin Pharmacol Toxicol 2004 0.75